About us

Fibronostics is a global diagnostics company, shaping the future of non-invasive diagnostics with artificial intelligence that provides algorithm-based solutions in a variety of diagnostic testing areas, focusing on screening, progression and prognosis of liver & kidney disease, and other chronic conditions. (HBV, HCV, NAFLD, NASH and ALD ).

The company is incorporated in Singapore & New York and is currently commercialized in North America, Asia, Europe and LATAM. Fibronostics is a SPRIM portfolio company with a pedigree in worldwide health innovation, research & consulting.

Fibronsotics mission

Our Mission

To improve human health with the science of diagnostic algorithm and artificial intelligence.

Our Team

Roni Amiel Fibronostics CEO

Roni H. Amiel

Chief Executive Officer


Chief Medical Officer Fibronostics

Dr. Ronald Quiambao

Chief Medical Officer


Chief Financial Officer Fibronostics

Dr. Mona Munteanu

Chief Scientific Officer


Chief Commercial Officer Fibronostics

Missy Martin-Kemp

Chief Commercial Officer


Chief Financial Officer Fibronostics

Craig Gavina

Chief Technical Officer


Chief Financial Officer Fibronostics

Thomas Fratacci

Chief Financial Officer


Boards of Directors

Business Development Manager Fibronostics

Michael Shleifer PhD

Co-founder and Managing Partner


Business Development Manager Fibronostics

Laurent Benissan

Managing Partner SPRIM VENTURES


Business Development Manager Fibronostics

Ivan Jarry

Co-founder and Managing Partner


Advisory Board

Founder and Retired President Health Plan Alliance Fibronostics

Cathy Eddy

Founder and Retired President Health Plan Alliance


Clinical Associate Professor of Medicine Texas A&M University

Dr. Imtiaz Alam

Clinical Associate Professor of Medicine Texas A&M University


Clinical Associate Professor of Medicine Texas A&M University

Dr. Stephen A. Harrison

Medical Director of Pinnacle Clinical Research

Medical Technology SPRIM VENTURES

Sven Henrichwark

Medical Technology SPRIM VENTURES


Medical Technology SPRIM VENTURES

Dr. Victor de Lédinghen

Head of the Hepatology & Liver Transplantation Unit, Bordeaux University Hospital


Non-invasive Diagnostic Technology